Interactions between the Class II Transactivator and CREB Binding Protein Increase Transcription of Major Histocompatibility Complex Class II Genes

REFERENCES

• Aarnisalo, P., J. J. Palvimo, and J. Janne 1998. CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 95:2122–2127.
   PubMed Web of Science ®Google Scholar
• Abdulkadir, S. A., and J. Ono 1995. How are class II MHC genes turned on and off? FASEB J. 9:1429–1435.
   PubMedGoogle Scholar
• Abraham, S. E., S. Lobo, P. Yaciuk, H. G. Wang, and J. Moran 1993. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8:1639–1647.
   PubMedGoogle Scholar
• Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and J. Eckner 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81–84.
   PubMed Web of Science ®Google Scholar
• Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and J. Montminy 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226–229.
   PubMed Web of Science ®Google Scholar
• Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and J. Kelly 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175–1184.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and J. Kouzarides 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641–643.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and J. Kouzarides 1995. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14:4758–4762.
   PubMed Web of Science ®Google Scholar
• Celada, A., S. McKercher, and J. Maki 1993. Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J. Exp. Med. 177:691–698.
   PubMedGoogle Scholar
• Chang, C. H., J. D. Fontes, M. Peterlin, and J. Flavell 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367–1374.
   PubMedGoogle Scholar
• Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and J. Evans 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569–580.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and J. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and J. Goodman 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855–859.
   PubMed Web of Science ®Google Scholar
• Dallas, P. B., P. Yaciuk, and J. Moran 1997. Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J. Virol. 71:1726–1731.
   PubMedGoogle Scholar
• Durand, B., M. Kobr, W. Reith, and J. Mach 1994. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol. Cell. Biol. 14:6839–6847.
   PubMedGoogle Scholar
• Fontes, J. D., N. Jabrane-Ferrat, and J. Peterlin 1997. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270:336–345.
   PubMedGoogle Scholar
• Fontes, J. D., N. Jabrane-Ferrat, C. R. Toth, and J. Peterlin 1996. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. Med. 183:2517–2521.
   PubMedGoogle Scholar
• Fontes, J. D., B. Jiang, and J. Peterlin 1997. The class II transactivator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:2522–2528.
   PubMed Web of Science ®Google Scholar
• Goldman, P. S., V. K. Tran, and J. Goodman 1997. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Horm. Res. 52:103–119.
   PubMedGoogle Scholar
• Imhof, A., X. J. Yang, V. V. Ogryzko, Y. Nakatani, A. P. Wolffe, and J. Ge 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:689–692.
   PubMed Web of Science ®Google Scholar
• Jabrane-Ferrat, N., J. D. Fontes, J. M. Boss, and J. Peterlin 1996. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16:4683–4690.
   PubMedGoogle Scholar
• Janknecht, R., and J. Hunter 1996. Versatile molecular glue. Transcriptional control. Curr. Biol. 6:951–954.
   PubMed Web of Science ®Google Scholar
• Jonat, C., H. J. Rahmsdorf, K. K. Park, A. C. Cato, S. Gebel, H. Ponta, and J. Herrlich 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189–1204.
   PubMed Web of Science ®Google Scholar
• Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and J. Rosenfeld 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
   PubMed Web of Science ®Google Scholar
• Kara, C. J., and J. Glimcher 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709–712.
   PubMedGoogle Scholar
• Kee, B. L., J. Arias, and J. Montminy 1996. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J. Biol. Chem. 271:2373–2375.
   PubMedGoogle Scholar
• Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bächinger, R. G. Brennan, S. G. Roberts, M. R. Green, and J. Goodman 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:223–226.
   PubMed Web of Science ®Google Scholar
• Lin, Y. S., M. F. Carey, M. Ptashne, and J. Green 1988. GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell 54:659–664.
   PubMedGoogle Scholar
• Linhoff, M. W., K. L. Wright, and J. Ting 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589–4596.
   PubMedGoogle Scholar
• Louis-Plence, P., C. S. Moreno, and J. Boss 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:3899–3909.
   PubMedGoogle Scholar
• Lucibello, F. C., E. P. Slater, K. U. Jooss, M. Beato, and J. Müller 1990. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9:2827–2834.
   PubMedGoogle Scholar
• Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and J. Goodman 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85–88.
   PubMed Web of Science ®Google Scholar
• Mach, B., V. Steimle, E. Martinez-Soria, and J. Reith 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301–331.
   PubMed Web of Science ®Google Scholar
• Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. Boss 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313–4321.
   PubMedGoogle Scholar
• Nakajima, T., A. Fukamizu, J. Takahashi, F. H. Gage, T. Fisher, J. Blenis, and J. Montminy 1996. The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 86:465–474.
   PubMedGoogle Scholar
• Nakajima, T., C. Uchida, S. F. Anderson, C. G. Lee, J. Hurwitz, J. D. Parvin, and J. Montminy 1997. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90:1107–1112.
   PubMedGoogle Scholar
• Nakajima, T., C. Uchida, S. F. Anderson, J. D. Parvin, and J. Montminy 1997. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11:738–747.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and J. Nakatani 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
   PubMed Web of Science ®Google Scholar
• Parker, D., K. Ferreri, T. Nakajima, V. J. LaMorte, R. Evans, S. C. Koerber, C. Hoeger, and J. Montminy 1996. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol. Cell. Biol. 16:694–703.
   PubMed Web of Science ®Google Scholar
• Parry, G. C., and J. Mackman 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159:5450–5456.
   PubMed Web of Science ®Google Scholar
• Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and J. Mach 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020–20025.
   PubMedGoogle Scholar
• Reith, W., C. A. Siegrist, B. Durand, E. Barras, and J. Mach 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554–558.
   PubMedGoogle Scholar
• Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. Boss 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533–543.
   PubMedGoogle Scholar
• Sartorelli, V., J. Huang, Y. Hamamori, and J. Kedes 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010–1026.
   PubMed Web of Science ®Google Scholar
• Scholl, T., S. K. Mahanta, and J. Strominger 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330–6334.
   PubMedGoogle Scholar
• Schüle, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and J. Evans 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217–1226.
   PubMed Web of Science ®Google Scholar
• Schwiebert, L. M., R. P. Schleimer, S. F. Radka, and J. Ono 1995. Modulation of MHC class II expression in human cells by dexamethasone. Cell. Immunol. 165:12–19.
   PubMed Web of Science ®Google Scholar
• Silacci, P., A. Mottet, V. Steimle, W. Reith, and J. Mach 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329–1336.
   PubMed Web of Science ®Google Scholar
• Steimle, V., L. A. Otten, M. Zufferey, and J. Mach 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135–146.
   PubMed Web of Science ®Google Scholar
• Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and J. Mach 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106–109.
   PubMed Web of Science ®Google Scholar
• Tanaka, H., Y. Makino, T. Miura, F. Hirano, K. Okamoto, K. Komura, Y. Sato, and J. Makino 1996. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J. Immunol. 156:1601–1608.
   PubMed Web of Science ®Google Scholar
• Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. Ting 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042–4053.
   PubMedGoogle Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and J. Nakatani 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324.
   PubMed Web of Science ®Google Scholar
• Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and J. Karin 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205–1215.
   PubMed Web of Science ®Google Scholar
• Zhou, H., and J. Glimcher 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545–553.
   PubMedGoogle Scholar